Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer
Manuela Milani(Humanitas University), Giandomenico Roviello(University of Florence), Daniele Generali(University of Trieste), Alberto Bottini(University of Genoa), Sergio Venturini(University of Turin), Maria Rosa Cappelletti(University of Trieste), Giovanni Allevi(Istituti Ospitalieri di Cremona), Sergio Aguggini(Istituti Ospitalieri di Cremona), Carla Strina(Istituti Ospitalieri di Cremona), Silvia Paola Corona(Hôpital Cardiologique du Haut-Lévêque), Adrian L. Harris(University of Oxford), Stephen B. Fox(Peter MacCallum Cancer Centre), Kevin C. Gatter(John Radcliffe Hospital), Simone Bonardi(Istituti Ospitalieri di Cremona), Alfredo Berruti(Surgical Specialties (Canada)), Leticia Campo(University of Oxford), Adrian M. Jubb(Allogene Therapeutics (United States))
Cited by 12
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k